Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCETAXEL vs ERIBULIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOCETAXEL vs ERIBULIN: Safety Overview

Metric DOCETAXEL ERIBULIN
Total FAERS Reports 64,992 5,055
Deaths Reported 6,068 793
Death Rate 9.3% 15.7%
Hospitalizations 13,463 2,642
Average Patient Age 56.0 yrs 57.3 yrs
% Female Patients 83.4% 93.0%
FDA Approval Date Apr 1, 2019 Apr 5, 2024
Manufacturer Mylan Institutional LLC Gland Pharma Limited
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued Prescription